Work

CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma

Year: 2011

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-011-1123-2

Authors: Sungyoul Hong, Jianfei Qian, Haiyan Li, Jing Yang, Yong Lu, Yuhuan Zheng, Qing Yi

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1353051725, G2477823829, G2715977583, Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma, Optimizing Dendritic Cell Immunotherapy in Myeloma, G8201990307, G920387048

OpenAlex ID: W1986017953

FWCI: 0.981

Cites: 47

Cited by: 20

Related to: 10